Prognostic role of microRNAs in breast cancer: A systematic review
Metrics: PDF 1654 views | Full Text 3194 views | ?
Eleni Zografos1, Flora Zagouri2, Despoina Kalapanida2, Roubini Zakopoulou2, Anastasios Kyriazoglou2, Kleoniki Apostolidou2, Maria Gazouli1 and Meletios-Athanasios Dimopoulos2
1 Department of Basic Medical Sciences, Laboratory of Biology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
2 Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
|Eleni Zografos,||email:||el_[email protected]|
Keywords: breast cancer; microRNAs; prognosis; biomarkers
Received: August 07, 2019 Accepted: October 26, 2019 Published: December 24, 2019
MicroRNAs (miRNAs) have been found to play an important role in breast cancer, functioning either as potential oncogenes or tumor suppressor genes, but their role in the prognosis of patients remains unclear. The aim of the present review study is to highlight recent preclinical and clinical studies performed on both circulating and tissue-specific miRNAs and their potential role as prognostic markers in breast cancer. We systematically searched the PubMed database to explore the prognostic value of miRNAs in breast cancer. After performing the literature search and review, 117 eligible studies were identified. We found that 110 aberrantly expressed miRNAs have been associated with prognosis in breast cancer. In conclusion, the collective data presented in this review indicate that miRNAs could serve as novel prognostic tools in breast cancer, while the clinical application of these findings has yet to be verified.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.